Security key
89854M101
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)
CUSIP: 89854M101
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Voting Common Stock, $0.0001 par value per share
- Shares outstanding
- 55,838,719
- Total 13F shares
- 40,135,840
- Share change
- -1,373,617
- Total reported value
- $55,389,702
- Price per share
- $1.38
- Number of holders
- 92
- Value change
- -$2,855,488
- Number of buys
- 49
- Number of sells
- 30
Report period
Q1 2025
Institutions
92
Top holders
10
TCRX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
TScan Therapeutics, Inc. SEC filings
TScan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89854M101
Recent filing periods:
Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
13D/G
|
Company · Adage Capital Management, L.P. |
7.1%
from 13D/G
|
3,500,000
|
$10,640,000 | — | 31 Dec 2024 | |
| K2 HealthVentures Equity Trust LLC |
13D/G
|
— |
6.9%
|
3,602,700
|
$5,764,320 | $0 | 31 Dec 2024 | |
| EcoR1 Capital, LLC |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
1.3%
from 13D/G
|
5,000,000
|
$24,842,500 | — | 26 May 2023 | |
| Lynx1 Capital Management LP |
13F
|
Company |
9.6%
|
5,357,347
|
$16,286,335 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.9%
|
4,961,700
|
$15,083,567 | — | 31 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
5.4%
|
2,989,474
|
$9,088,001 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5%
|
2,784,792
|
$8,465,768 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
2,382,533
|
$7,242,900 | — | 31 Dec 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
3.7%
|
2,087,139
|
$6,344,903 | — | 31 Dec 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
3.1%
|
1,755,987
|
$5,338,200 | — | 31 Dec 2024 | |
| Deer Management Co. LLC |
13F
|
Company |
2.2%
|
1,245,504
|
$3,786,332 | — | 31 Dec 2024 | |
| Alphabet Inc. |
13F
|
Company |
1.9%
|
1,077,080
|
$3,274,323 | — | 31 Dec 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
1.9%
|
1,046,916
|
$3,182,625 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
963,257
|
$2,929,040 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
1.6%
|
883,704
|
$2,686,460 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
800,948
|
$2,434,882 | — | 31 Dec 2024 | |
| DC Funds, LP |
13F
|
Company |
1.1%
|
630,000
|
$1,915,200 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
412,858
|
$1,255,089 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
322,096
|
$979,172 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.5%
|
280,028
|
$851,187 | — | 31 Dec 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.47%
|
260,870
|
$793,045 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.29%
|
160,673
|
$488,446 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.27%
|
150,114
|
$456,346 | — | 31 Dec 2024 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0.26%
|
143,051
|
$434,875 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
142,617
|
$433,556 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.24%
|
132,895
|
$404,000 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
117,847
|
$358,255 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.21%
|
115,866
|
$352,233 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
112,941
|
$343,341 | — | 31 Dec 2024 | |
| Dauntless Investment Group, LLC |
13F
|
Company |
0.2%
|
110,345
|
$335,449 | — | 31 Dec 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.2%
|
109,700
|
$333,488 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
105,900
|
$321,936 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
91,860
|
$279,254 | — | 31 Dec 2024 | |
| NewEdge Wealth, LLC |
13F
|
Company |
0.16%
|
91,463
|
$278,048 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
88,314
|
$268,475 | — | 31 Dec 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.13%
|
71,800
|
$218,272 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
69,962
|
$212,684 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
67,508
|
$205,224 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
66,756
|
$202,938 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.12%
|
65,139
|
$198,023 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.11%
|
63,095
|
$191,809 | — | 31 Dec 2024 | |
| Troluce Capital Advisors LLC |
13F
|
Company |
0.09%
|
52,914
|
$160,859 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
46,807
|
$142,287 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
43,969
|
$133,666 | — | 31 Dec 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
0.08%
|
43,723
|
$132,918 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
40,243
|
$122,339 | — | 31 Dec 2024 | |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
|
Company |
0.06%
|
36,200
|
$110,048 | — | 31 Dec 2024 | |
| DC Investments Management, LLC |
13F
|
Company |
0.06%
|
35,563
|
$108,112 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
25,835
|
$78,538 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
22,214
|
$67,531 | — | 31 Dec 2024 |
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX) as of Q1 2025
As of 31 Mar 2025,
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,135,840 shares.
The largest 10 holders included
Lynx1 Capital Management LP, BVF INC/IL, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Propel Bio Management, LLC, Checkpoint Capital L.P., Deer Management Co. LLC, and Alphabet Inc..
This page lists
92
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
87
Q1 2025 holders
92
Holder diff
5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.